Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature

References

• Guengerich FP. Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol. 1996;43:7–35.
   Google Scholar
• Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther. 2005;77:415–426.
   PubMed Web of Science ®Google Scholar
• Wang Z, Gorski JC, Hamman MA, et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther. 2001;70:317–326.
   PubMed Web of Science ®Google Scholar
• Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab. 2006;7:67–81.
   PubMed Web of Science ®Google Scholar
• Sandgren A, Strong M, Muthukrishnan P, et al. Tuberculosis drug resistance mutation database. PLoS Med. 2009;6:e2.
   PubMed Web of Science ®Google Scholar
• Balaban NQ, Gerdes K, Lewis K, et al. A problem of persistence: still more questions than answers? Nat Rev Microbiol. 2013;11:587–591.
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. The Lancet. 2001;358:135–138.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591.
   PubMed Web of Science ®Google Scholar
• Pauling L, Robinson AB, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci. 1971;68:2374–2376.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Resp Crit Care. 2011;184(5):602–615.
   PubMed Web of Science ®Google Scholar
• Craig H. Isotopic standards for carbon and oxygen and correction factors for mass-spectrometric analysis of carbon dioxide. Geochimica et cosmochimica acta. 1957;12:133–149.
   Web of Science ®Google Scholar
• Pfaffenbach B, Wegener M, Adamek R, et al. [Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal–correlation with scintigraphy in diabetic patients and reproducibility in healthy probands]. Zeitschrift fur Gastroenterologie. 1995;33:141–145.
   PubMed Web of Science ®Google Scholar
• Stamyr K, Vaittinen O, Jaakola J, et al. Background levels of hydrogen cyanide in human breath measured by infrared cavity ring down spectroscopy. Biomarkers. 2009;14:285–291.
   PubMed Web of Science ®Google Scholar
• Enderby B, Smith D, Carroll W, et al. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol. 2009;44:142–147.
   PubMed Web of Science ®Google Scholar
• Castric PA. Glycine metabolism by Pseudomonas aeruginosa: hydrogen cyanide biosynthesis. J Bacteriol. 1977;130:826–831.
   PubMed Web of Science ®Google Scholar
• Laville J, Blumer C, Von Schroetter C, et al. Characterization of the hcnABC gene cluster encoding hydrogen cyanide synthase and anaerobic regulation by ANR in the strictly aerobic biocontrol agent Pseudomonas fluorescens CHA0. J Bacteriol. 1998;180:3187–3196.
   PubMed Web of Science ®Google Scholar
• Timmins GS. Detecting virulence and drug-resistance mycobacterial phenotypes in vivo. Trends Microbiol. 2015;23:321–323.
   PubMed Web of Science ®Google Scholar
• Raissy HH, Timmins GS, Davies L, et al. A proof of concept study to detect urease producing bacteria in lungs using aerosolized 13C urea. Pediatr Allergy Immunol Pulmonol. 2016;29:68–73.
   Web of Science ®Google Scholar
• Melker RJ, Dennis DM, Batich CD, et al. Medication adherence monitoring system. USPTO 20140364384. 2014.
   Google Scholar
• Keidan I Providing evidence whether an intravascular conduit is correctly positioned. USPTO 20140330152. 2012.
   Google Scholar
• Cook ME, Whigham LD, Butz DE, et al. Methods of determining energy balance using breath carbon isotope ratios. USPTO, 20150196248. 2014.
   Google Scholar
• Shen J, Yang T Sniffing smartphone. USPTO 20150141073. 2015, issued as 9188579.
   Google Scholar
• Inada M, Kunizaki JI, Tobita K, et al. Method for measuring carbohydrate metabolism ability, and composition for use in said method. USPTO 20150204852. 2013.
   Google Scholar
• Guggenheim G, Ben-Oren I, Hershkowitz A, et al. Methods For Diagnosis, Prognosis, Monitoring And Treatment Of Hepatocellular Carcinoma. USPTO 20140033795. 2013.
   Google Scholar
• Williams CE, Crabtree SA Gastric emptying breath tests. USPTO 20140379267. 2013.
   Google Scholar
• Bush KC Single-point gastric emptying breath tests. USPTO 20140276172. 2013.
   Google Scholar
• Ben-Oren I, Guggenheim G, Hershkowitz A, et al. Breath test device and method. USPTO 20140024953. 2013.
   Google Scholar
• Eghbalnia HR, Cook ME, Porter WP, et al. Detection of rate changes in systematic oscillations of metabolic athways by monitoring isotope ratios. USPTO 20130236925. 2013, issued as 8512676.
   Google Scholar
• Fink M, Varghese P, Borysow J Superior analyzer for raman spectra with high acceptance cone, resolution, transmission, quantum efficiency, and strong background reduction. USPTO 20130162988. 2013, issued as 8675191.
   Google Scholar
• Berman ES, Speakman JR, Gupta M, et al. Triple isotope method and analyzer for total energy expenditure measurements. USPTO 20130027705. 2013, issued as 8823923.
   Google Scholar
• Gabriel PM Stable isotopic biomarker measurement for the detection of cancer and the determination of efficacy of treatment in diagnosed cancer patients. USPTO 20130011872. 2013.
   Google Scholar
• Flockhart DA, Desta Z, Modak AS, et al. Methods to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test. USPTO 20110111510 2010.
   Google Scholar
• Heyne K Method for determining the liver performance of a living organism by the means of quantitative measuring the metabolization of substrates. USPTO 20110313677. 2010.
   Google Scholar
• Konopka SJ, Sanda RW Fluid bed meal containing a marker and methods of making. USPTO 20110223104. 2014, issued as 8753609.
   Google Scholar
• Modak AS, Irie Y, Kurogi Y Method and Composition to Evaluate Cytochrome P450 2D6 Isoenzyme Activity Using a Breath Test. USPTO 20100329979. 2010.
   Google Scholar
• Oren IB, Guggenheim G, Hershkowitz A, et al. Breath test device and method. USPTO 20140024953. 2010.
   Google Scholar
• Timmins GS. Deuterated drugs: where are we now? Expert Opin Ther Pat. 2014;24:1067–1075.
   PubMed Web of Science ®Google Scholar
• Watts R, Crawhall J. The first glycine metabolic pool in man. Biochem J. 1959;73:277.
   PubMed Web of Science ®Google Scholar
• Timmins G, Choi S, Sharp Z, et al. Methods of using isoniazid for the diagnosis of lung infections. USPTO 20150104819. 2015.
   Google Scholar
• Choi SW, Maiga M, Maiga MC, et al. Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test. Nat Commun. 2014;5:4989.
   PubMed Web of Science ®Google Scholar
• Assadi-Porter FM, Cook ME, Porter WP, et al. Identification Of Disease Characteristics Using Isotope Ratios In Breath. USPTO 20130066224. 2013, issued as 8852117.
   Google Scholar
• Perkett EA Determination Of Location Of Bacterial Load In The Lungs. USPTO 20140179809. 2014.
   Google Scholar
• Rigas B, Rigas A, Gouma PI, et al. Detection of H. pylori using unlabeled urea. USPTO 20120034646. 2012.
   Google Scholar
• Graham D, Evans D, Alpert L, et al. Campylobacter pylori detected noninvasively by the 13 C-urea breath test. The Lancet. 1987;329:1174–1177.
   Google Scholar
• Bell G, Weil J, Harrison G, et al. 14 C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. The Lancet. 1987;329:1367–1368.
   Google Scholar
• Kajiwara M, Urita Y, Nonomura H Diagnostic agent and diagnostic method for irritable bowel syndrome induced by abnormal proliferation of enterobacteria. USPTO 20150050744. 2015.
   Google Scholar
• Timmins G, Silks LP Methods for diagnosing bacterial infections. USPTO 20150275265. 2015.
   Google Scholar
• Timmins G, Wu T, Choi SW Compositions and kits for diagnosing infections. USPTO 20150125898. 2015.
   Google Scholar
• Timmins G, Wu T, Choi SW Rapid test for detection of infection and therapeutic response. USPTO 20140212916. 2014, issued as 9074237.
   Google Scholar
• Rigas B, Rigas A, Gouma PI, et al. Detection of h. pylori utilizing unlabeled urea. USPTO 20120034646. 2012, issued as 9289155.
   Google Scholar
• Timmins G, Deretic VP Diagnosis of infection in the lungs of patients. USPTO RE44533. 2012.
   Google Scholar
• Lin HC, Pimentel M Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions. USPTO 20100209507. 2010, issued as 8110177.
   Google Scholar
• Timmins G, Deretic VP Non-Invasive Rapid Diagnostic Test For M.Tuberculosis Infection. USPTO 20090191639. 2009, issued as 7897400.
   Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197:1079–1081.
   PubMed Web of Science ®Google Scholar
• Harvey A, Modak A, Déry U, et al. Changes in CYP2C19 enzyme activity evaluated by the [13C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity. J Breath Res. 2016;10:017104.
   PubMed Web of Science ®Google Scholar
• Klieber M, Oberacher H, Hofstaetter S, et al. CYP2C19 phenoconversion by routinely prescribed proton pump inhibitors omeprazole and esomeprazole: clinical implications for personalized medicine. J Pharmacol Exp Ther. 2015;354:426–430.
   PubMed Web of Science ®Google Scholar
• Safgren SL, Suman VJ, Kosel ML, et al. Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen. Pharmacogenet Genomics. 2015;25:157–163.
   PubMed Web of Science ®Google Scholar
• Opdam F, Modak A, Gelderblom H, et al. Further characterization of a 13C-dextromethorphan breath test for CYP2D6 phenotyping in breast cancer patients on tamoxifen therapy. J Breath Res. 2015;9:026003.
   PubMed Web of Science ®Google Scholar
• Arazy M, Hershkowitz A Prediction value of the breathID 13C-methacetin breath test for hepatic decompensation NCT02084160. clinicaltrials.gov. 2014.
   Google Scholar
• Steingötter A, Parker H 13C trioctanoate breath test as a measurement of gastric fat volume emptying (13CTriOBT) NCT02602158. Clinicaltrials.gov. 2016.
   Google Scholar
• Rotman Y Palmitate breath test to assess fatty acid oxidation in Non Alcoholic Fatty Liver Disease (NAFLD) NCT02363309. clinicaltrials.gov. 2016.
   Google Scholar
• O’Rourke A Changes in 13CO2/12CO2 delta value in exhaled breath as an early indicator of infection in adult trauma subjects NCT02258022. clinicaltrials.gov. 2016.
   Google Scholar
• Butz D Changes in Exhaled 13CO2/12CO2 breath delta value as an early indicator of infection in ICU patients NCT02327130. clinicaltrials.gov. 2016.
   Google Scholar
• Casperson S The breathe light study NCT01976455. clinicaltrials.gov. 2016.
   Google Scholar
• Peres DR OBT measurement to differentiate between presence and absence of HCC determined by MRI NCT02415283. clinical trials.gov. 2015.
   Google Scholar
• Hershkowitz A Assessing portal hypertension with methacetin breath test NCT02143778. clinicaltrials.gov, 2014.
   Google Scholar
• McCue MD, Welch KC Jr. 13C-breath testing in animals: theory, applications, and future directions.J Comp Physiol B.2016;186:265–285.
   PubMed Web of Science ®Google Scholar